论文部分内容阅读
目的:对1例Say-Barber-Biesecker-Young-Simpson综合征患儿的n KAT6B基因变异进行分析，明确其可能的致病原因。n 方法:提取患儿及双亲外周血DNA，应用全外显子基因组测序法检测相关基因变异，并通过Sanger测序法验证可疑变异，对其进行生物信息学预测。结果:全外显子基因组测序结果显示患儿n KAT6B基因第13外显子存在c.2623C>T (p.Asp875Tyr)错义变异，该变异既往未见报道，且为新发(n de novo)变异(PS2)，在主要人群基因频率数据库中均不存在(PM2)。经PolyPhen-2、MutationTaster、PROVEAN等软件预测，均提示c.2623C>T (p.Asp875Tyr)变异为有害变异；同时经UCSF chimera及CASTp软件对编码蛋白3D结构进行建模及酶活性位点定位，发现该氨基酸的改变可影响编码蛋白原有的酶结合口袋空间大小，进而影响其与底物结合的能力，导致原有酶功能丧失(PP3)。根据美国医学遗传学与基因组学学会指南判定为可能致病变异(PS2+PM2+PP3)。n 结论:KAT6B基因c.2623C>T(p.Asp875Tyr)变异可能为该患儿罹患Say-Barber-Biesecker-Young-Simpson综合征的原因。n “,”Objective:To explore the genetic basis for a child suspected for Say-Barber-Biesecker-Young-Simpson syndrome.Methods:Genomic DNA was extracted from peripheral blood samples of the child and her parents. Whole exome sequencing was carried out for the proband. Suspected variants were validated by Sanger sequencing. The impact of the variants was predicted by bioinformatic analysis.Results:The child was found to harbor a n de novo missense variant c. 2623C>T (p.Asp875Tyr) in exon 13 of then KAT6B gene. The variant was previously unreported, and was not recorded in the major allele frequency database and predicted to be pathogenic based on PolyPhen-2, MutationTaster and PROVEAN analysis. As predicted by UCSF chimera and CASTp software, the variant can severely impact the substrate-binding pocket of histone acethyltransferase, resulting in loss of its enzymatic activity. Based on standards and guidelines by the American College of Medical Genetics and Genomics, the variant was classified to be likely pathogenic (PS2+ PM2+ PP3).n Conclusion:The child’s condition may be attributed to the n de novo missense c. 2623C>T (p.Asp875Tyr) variant of then KAT6B gene.n